|
1
|
Pascual V, Díaz JL, Millán Nuñez-Cortés J, Pérez-Martínez P. Nutritional recommendations in the prevention and treatment of atherogenic dyslipidemia. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS : PUBLICACION OFICIAL DE LA SOCIEDAD ESPANOLA DE ARTERIOSCLEROSIS 2023; 35:155-163. [PMID: 36400610 DOI: 10.1016/j.arteri.2022.09.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/28/2022] [Accepted: 09/29/2022] [Indexed: 11/17/2022]
Abstract
The incorporation of a healthy diet, regular physical exercise and smoking cessation are the initial measures to reduce cardiovascular risk in patients with atherogenic dyslipidemia. In these patients, the nutritional quality of their diet should be improved, replacing foods with a greater atherogenic effect for others with a healthier effect. There is strong evidence that plant-based dietary patterns, low in saturated fatty acids, cholesterol and sodium, with a high content of fiber, potassium and unsaturated fatty acids, are beneficial and reduce the expression of cardiovascular risk factors. This document focuses on the role of nutrition in the prevention and treatment of atherogenic dyslipidemia, providing current evidence to serve as a tool for health professionals in its clinical management. To facilitate the reading of these recommendations, they are presented in a user-friendly table format, with a hierarchy of different levels of evidence.
Collapse
Affiliation(s)
- Vicente Pascual
- Centro de Salud Palleter, Universidad CEU-Cardenal Herrera, Castellón, España; Grupo de Trabajo Dislipemia Aterogénica, Sociedad Española de Arteriosclerosis (SEA), España; Grupo de Trabajo Nutrición y Estilo de Vida, Sociedad Española de Arteriosclerosis (SEA), España
| | - José Luis Díaz
- Grupo de Trabajo Dislipemia Aterogénica, Sociedad Española de Arteriosclerosis (SEA), España; Unidad de Lípidos y Riesgo Cardiovascular, Medicina Interna, Hospital Universitario A Coruña, A Coruña, España
| | - Jesús Millán Nuñez-Cortés
- Grupo de Trabajo Dislipemia Aterogénica, Sociedad Española de Arteriosclerosis (SEA), España; Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, España
| | - Pablo Pérez-Martínez
- Grupo de Trabajo Dislipemia Aterogénica, Sociedad Española de Arteriosclerosis (SEA), España; Grupo de Trabajo Nutrición y Estilo de Vida, Sociedad Española de Arteriosclerosis (SEA), España; Unidad de Lípidos y Arterioesclerosis, Universidad de Córdoba/Hospital Universitario Reina Sofía/Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, España; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, España.
| |
Collapse
|
|
2
|
Sanchez-Morate E, Gimeno-Mallench L, Stromsnes K, Sanz-Ros J, Román-Domínguez A, Parejo-Pedrajas S, Inglés M, Olaso G, Gambini J, Mas-Bargues C. Relationship between Diet, Microbiota, and Healthy Aging. Biomedicines 2020; 8:E287. [PMID: 32823858 PMCID: PMC7460310 DOI: 10.3390/biomedicines8080287] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2020] [Revised: 08/04/2020] [Accepted: 08/06/2020] [Indexed: 12/15/2022] Open
Abstract
Due to medical advances and lifestyle changes, population life expectancy has increased. For this reason, it is important to achieve healthy aging by reducing the risk factors causing damage and pathologies associated with age. Through nutrition, one of the pillars of health, we are able to modify these factors through modulation of the intestinal microbiota. The Mediterranean and Oriental diets are proof of this, as well as the components present in them, such as fiber and polyphenols. These generate beneficial effects on the body thanks, in part, to their interaction with intestinal bacteria. Likewise, the low consumption of products with high fat content favors the state of the microbiota, contributing to the maintenance of good health.
Collapse
Affiliation(s)
- Elisa Sanchez-Morate
- Freshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, CIBERFES-ISCIII, INCLIVA, 46010 Valencia, Spain; (E.S.-M.); (L.G.-M.); (K.S.); (J.S.-R.); (A.R.-D.); (S.P.-P.); (G.O.); (C.M.-B.)
| | - Lucia Gimeno-Mallench
- Freshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, CIBERFES-ISCIII, INCLIVA, 46010 Valencia, Spain; (E.S.-M.); (L.G.-M.); (K.S.); (J.S.-R.); (A.R.-D.); (S.P.-P.); (G.O.); (C.M.-B.)
- Department of Biomedical Sciences, Faculty of Health Sciences, Cardenal Herrera CEU University, 46115 Valencia, Spain
| | - Kristine Stromsnes
- Freshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, CIBERFES-ISCIII, INCLIVA, 46010 Valencia, Spain; (E.S.-M.); (L.G.-M.); (K.S.); (J.S.-R.); (A.R.-D.); (S.P.-P.); (G.O.); (C.M.-B.)
| | - Jorge Sanz-Ros
- Freshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, CIBERFES-ISCIII, INCLIVA, 46010 Valencia, Spain; (E.S.-M.); (L.G.-M.); (K.S.); (J.S.-R.); (A.R.-D.); (S.P.-P.); (G.O.); (C.M.-B.)
| | - Aurora Román-Domínguez
- Freshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, CIBERFES-ISCIII, INCLIVA, 46010 Valencia, Spain; (E.S.-M.); (L.G.-M.); (K.S.); (J.S.-R.); (A.R.-D.); (S.P.-P.); (G.O.); (C.M.-B.)
| | - Sergi Parejo-Pedrajas
- Freshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, CIBERFES-ISCIII, INCLIVA, 46010 Valencia, Spain; (E.S.-M.); (L.G.-M.); (K.S.); (J.S.-R.); (A.R.-D.); (S.P.-P.); (G.O.); (C.M.-B.)
| | - Marta Inglés
- Freshage Research Group, Department of Physiotherapy, Faculty of Physiotherapy, University of Valencia, CIBERFES-ISCIII, INCLIVA, 46010 Valencia, Spain;
| | - Gloria Olaso
- Freshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, CIBERFES-ISCIII, INCLIVA, 46010 Valencia, Spain; (E.S.-M.); (L.G.-M.); (K.S.); (J.S.-R.); (A.R.-D.); (S.P.-P.); (G.O.); (C.M.-B.)
| | - Juan Gambini
- Freshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, CIBERFES-ISCIII, INCLIVA, 46010 Valencia, Spain; (E.S.-M.); (L.G.-M.); (K.S.); (J.S.-R.); (A.R.-D.); (S.P.-P.); (G.O.); (C.M.-B.)
| | - Cristina Mas-Bargues
- Freshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, CIBERFES-ISCIII, INCLIVA, 46010 Valencia, Spain; (E.S.-M.); (L.G.-M.); (K.S.); (J.S.-R.); (A.R.-D.); (S.P.-P.); (G.O.); (C.M.-B.)
| |
Collapse
|
|
3
|
Pallarés Carratalá V, Górriz-Zambrano C, Morillas Ariño C, Llisterri Caro JL, Gorriz JL. [COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?]. Semergen 2020; 46 Suppl 1:78-87. [PMID: 32448633 PMCID: PMC7211659 DOI: 10.1016/j.semerg.2020.05.005] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2020] [Accepted: 05/06/2020] [Indexed: 12/12/2022]
Abstract
The SARS-CoV-2 pandemic is a global health emergency and we need to know more about it. Patients with cardiovascular risk and previous kidney risk have been identified as especially vulnerable for greater morbidity and mortality when they suffer from COVID-19. A considerable proportion of patients can develop a vascular lesion in the context of the disease that entails a greater lethality. Cardiovascular and renal complications represent a problem and, probably in the near future, may pose a threat to patients who have survived COVID-19. As physicians, we cannot forget that during an epidemic like this, other chronic diseases are present, and patients continue to require care. We are obliged to monitor even more intensely their treatments and control degree. Furthermore, we must not forget that urgent situations continue to arise in this pandemic situation and require prompt attention. In this current situation, it is very likely that many patients, out of fear, have not sought medical attention. The situation during the epidemic and the uncertainty of the post-COVID-19 period, requires intensification in the control and monitoring of cardiovascular and kidney disease in our patients. Primary care constitutes a key level of care for the care of the population with cardiovascular disease. Likewise, and in the face of this new health scenario, we need to promote the prevention and control measures that emanate from the studies currently underway. Now, more than ever, we need research, crucial to improve the cardiovascular and renal prognosis of our patients.
Collapse
Affiliation(s)
- V Pallarés Carratalá
- Medicina Familiar y Comunitaria, Unidad de Vigilancia de la Salud, Unión de Mutuas, Castellón, España; Departamento de Medicina, Facultad de Ciencias de la Salud, Universitat JaumeI, Castellón, España.
| | - C Górriz-Zambrano
- Medicina Familiar y Comunitaria, CAP Sant Pere, ABS Reus1, Reus, Tarragona, España
| | - C Morillas Ariño
- Servicio de Endocrinología, Hospital Universitario Dr. Peset, Valencia, España; Departamento de Medicina, Facultad de Medicina, Universitat de València, Valencia, España
| | - J L Llisterri Caro
- Medicina Familiar y Comunitaria, Fundación de Investigación SEMERGEN (Madrid), Clínica Vallada, Valencia, España
| | - J L Gorriz
- Departamento de Medicina, Facultad de Medicina, Universitat de València, Valencia, España; Servicio de Nefrología, Hospital Clínico Universitario de Valencia, INCLIVA, Valencia, España
| |
Collapse
|